223 related articles for article (PubMed ID: 32408589)
21. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
Barth RH; DeVincenzo N
Kidney Int; 1996 Sep; 50(3):929-36. PubMed ID: 8872968
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Medium Cut-Off Dialyzer and Comparison with Standard High-Flux Hemodialysis.
Rambabova Bushljetik I; Trajceska L; Biljali S; Balkanov T; Dejanov P; Spasovski G
Blood Purif; 2021; 50(4-5):492-498. PubMed ID: 33291102
[TBL] [Abstract][Full Text] [Related]
23. Retention of beneficial molecules and coagulation factors during haemodialysis and haemodiafiltration.
Voigt M; Gebert M; Haug U; Hulko M; Storr M; Boschetti-de-Fierro A; Beck W; Krause B
Sci Rep; 2019 Apr; 9(1):6370. PubMed ID: 31015539
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
Mason NA; Neudeck BL; Welage LS; Patel JA; Swartz RD
Clin Nephrol; 2003 Aug; 60(2):96-104. PubMed ID: 12940611
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
[TBL] [Abstract][Full Text] [Related]
26. Rebound of plasma vancomycin levels after haemodialysis with highly permeable membranes.
Böhler J; Reetze-Bonorden P; Keller E; Kramer A; Schollmeyer PJ
Eur J Clin Pharmacol; 1992; 42(6):635-9. PubMed ID: 1623904
[TBL] [Abstract][Full Text] [Related]
27. NT-proBNP and troponin T levels differ after haemodialysis with a low versus high flux membrane.
Laveborn E; Lindmark K; Skagerlind M; Stegmayr B
Int J Artif Organs; 2015 Feb; 38(2):69-75. PubMed ID: 25744196
[TBL] [Abstract][Full Text] [Related]
28. Medium Cut-Off Dialysis Membrane and Dietary Fiber Effects on Inflammation and Protein-Bound Uremic Toxins: A Systematic Review and Protocol for an Interventional Study.
Herič T; Vivoda T; Bogataj Š; Pajek J
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33805509
[TBL] [Abstract][Full Text] [Related]
29. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.
Zickler D; Schindler R; Willy K; Martus P; Pawlak M; Storr M; Hulko M; Boehler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Fiedler R; Girndt M
PLoS One; 2017; 12(1):e0169024. PubMed ID: 28085888
[TBL] [Abstract][Full Text] [Related]
30. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
Ghouti-Terki L; Chasseuil E; Rabot N; Paintaud G; François M; Birmelé B; Darrouzain F; Büchler M; Halimi JM; Ternant D
Nephron; 2017; 135(4):261-267. PubMed ID: 28152540
[TBL] [Abstract][Full Text] [Related]
31. Impact of Medium Cut-Off Dialyzers on Patient-Reported Outcomes: COREXH Registry.
Alarcon JC; Bunch A; Ardila F; Zuñiga E; Vesga JI; Rivera A; Sánchez R; Sanabria RM;
Blood Purif; 2021; 50(1):110-118. PubMed ID: 33176299
[TBL] [Abstract][Full Text] [Related]
32. Differences in drug removal between standard high-flux and medium cut-off dialyzers in a case of severe vancomycin toxicity.
Aberger S; Kolland M; Eller K; Rosenkranz AR; Kirsch AH
Clin Kidney J; 2024 Apr; 17(4):sfae063. PubMed ID: 38887428
[TBL] [Abstract][Full Text] [Related]
33. Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis.
Decker BS; Kays MB; Chambers M; Kraus MA; Moe SM; Sowinski KM
Clin J Am Soc Nephrol; 2010 Nov; 5(11):1981-7. PubMed ID: 20616157
[TBL] [Abstract][Full Text] [Related]
34. Comparison of hemodialysis with medium cut-off dialyzer and on-line hemodiafiltration on the removal of small and middle-sized molecules
.
Belmouaz M; Diolez J; Bauwens M; Duthe F; Ecotiere L; Desport E; Bridoux F
Clin Nephrol; 2018 Jan; 89 (2018)(1):50-56. PubMed ID: 28853700
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of an in vitro dialysis system to predict drug removal.
Hudson JQ; Comstock TJ; Feldman GM
Nephrol Dial Transplant; 2004 Feb; 19(2):400-5. PubMed ID: 14736965
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the effects of three haemodialysis membranes on vancomycin disposition.
Alwakeel J; Najjar TA; al-Yamani MJ; Huraib S; al-Haider A; Abu-aisha H
Int Urol Nephrol; 1994; 26(2):223-8. PubMed ID: 8034435
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes.
DeSoi CA; Sahm DF; Umans JG
Am J Kidney Dis; 1992 Oct; 20(4):354-60. PubMed ID: 1415203
[TBL] [Abstract][Full Text] [Related]
38. Comparison of 2 medium cutoff dialyzers versus on-line hemodiafiltration regarding depurative ability and albumin loss: An uncontrolled clinical research.
Martínez-Miguel P; Gimena Muñoz R; Barrionuevo González M; López-Ongil S; Moro MÁ; Lizasoain I; Rodríguez-Puyol D; García Segura JM
Artif Organs; 2023 Mar; 47(3):589-594. PubMed ID: 36420938
[TBL] [Abstract][Full Text] [Related]
39. Dosage recommendation of vancomycin during haemodialysis with highly permeable membranes.
Zoer J; Schrander-van der Meer AM; van Dorp WT
Pharm World Sci; 1997 Aug; 19(4):191-6. PubMed ID: 9297732
[TBL] [Abstract][Full Text] [Related]
40. Effects of Medium Cut-Off Versus High-Flux Hemodialysis Membranes on Biomarkers: A Systematic Review and Meta-Analysis.
Kandi M; Brignardello-Petersen R; Couban R; Wu C; Nesrallah G
Can J Kidney Health Dis; 2022; 9():20543581211067090. PubMed ID: 35070336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
